Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 219 INDUSTRY 178 NIH 48 NETWORK 4 OTHER_GOV 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Neoplasms 4 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Tobacco Use Cessation 1 Tobacco Use 1 Solitary Pulmonary Nodule 1 Smoking 1 Small Cell Lung Carcinoma 1 Patient Compliance 1 Opioid-Related Disorders 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Lung Diseases, Obstructive 1 Liver Neoplasms 1 Kidney Diseases 1 Keratosis, Actinic 1 Fibrosis 1 Esophageal Neoplasms 1 Dementia 1 Colorectal Neoplasms 1 Chronic Pain 1 Chronic Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Bowel Preparation, Efficacy, Tolerability, Safety 1 Adenocarcinoma Of Esophagus 1

Interventions

relugolix 1 nilutamide 1 histrelin 1 enzalutamide 1 bicalutamide 1 apalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abiraterone 1 Triptorelin Pamoate 1 Prednisone 1 Methylprednisolone 1 Leuprolide 1 Goserelin 1 Flutamide 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Neoplasm Metastasis × 90 days × Clear all

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡